Vanda Pharmaceuticals (VNDA) Return on Invested Capital (2011 - 2026)

Vanda Pharmaceuticals' Return on Invested Capital history runs 11 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Invested Capital fell 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.01% for Q1 2026 at Vanda Pharmaceuticals, down from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2022 to a low of 0.01% in Q1 2026.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2022 and retreated 1 bps in 2025, its largest moves.
• Vanda Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2022, then sank by 248 bps to 0.0% in 2023, then tumbled by 520 bps to 0.0% in 2024, then plunged by 871 bps to 0.01% in 2025, then plunged by 39 bps to 0.01% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.01%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison